On the morning of February 22, Professor Wang Jianxun, the chief scientist of our company, and Sun Rui, the deputy director of research and development department, visited the research group of Professor Cao Zhiwei, Department of Biosestatistics and Computational Biology, School of Life Sciences, Fudan University. Professor Cao Zhiwei and his team members warmly received and held a seminar to share recent achievements and discuss cooperation issues.

At the seminar, Professor Cao Zhiwei's team shared the recent achievements of the cooperation project with Professor Wang Jianxun: the cross-protection antibodies screened from the Omikjon wild-type strain and its variant strains successfully predicted the epitopes with strong effects, and showed the latest research progress in the field of computational biology of its research group; Professor Wang Jianxun made a detailed introduction to the existing research and development pipelines and production pipelines of Shenzhen Cell Valley, and said that the deep cooperation with Professor Cao Zhiwei's school and enterprise has creative significance for the optimization of the existing CAR. The establishment of methodology in the field of computational biology can not only serve as a reference for the direction of follow-up scientific research, but also be applied to and serve the clinic. The teams of the two sides said that they should take this exchange visit as a new opportunity to strengthen the linkage and cooperation between schools and enterprises.

In order to solve the difficulties faced by the domestic cell and gene therapy industry, especially the lack of transformation support for the early research and development of pharmaceutical enterprises and scientific research institutes, Shenzhen Cell Valley has strengthened the layout of CRO services by using its strong scientific research strength, and has provided customers with one-stop CRO services since this year, covering virus vector design, vector production, modified cell production, and pre-clinical in vitro and in vivo efficacy validation experiments. At the same time, Shenzhen Cell Valley also provides CDMO services, clinical research services and IND application services, providing professional and thoughtful whole-process support for the transformation of scientific research achievements of scientists.